secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001818331-25-000070
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx Q1 revenue $87.1M, exome/genome revenue up 62% YoY; raises FY 2025 guidance
--------------------------------------------------------------------------------

- Q1 exome/genome revenue $71.4M (+62% YoY); total revenue $87.1M (+42% YoY).
- Adjusted net income $7.7M vs loss of $8.0M a year ago; GAAP net loss $6.5M.
- Announced plans to acquire Fabric Genomics; no deal value disclosed.
- Raised FY 2025 revenue guidance to $360-375M; reaffirms exome/genome growth of at least 30%.
- Adjusted gross margin improved to 69% from 61% YoY; cash $160.2M at quarter-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/0001818331-25-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833125000070/wgs-20250430.htm
  HTML page:      https://secwatch.observer/filing/0001818331-25-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer